Revelation Biosciences, Inc.

US$3.89As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:REVBHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (92.14%)
Div yield —
ROE (133.35%)
Biotechnology
Beta (5Y) (0.10)
PE TTM —
TSR TTM (88.89%)
Mkt cap US$2.214M
ROIC (83.44%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.97
2.08%
(79.12%)
Hold 1|10|11|7|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.05
0.31%
0.62%
(8.87%)
(0.86%)
Revenue$M
0.120
0.124
0.128
0.127
6.13%
6.34%
5.67%
8.10%
Peers (US$2.214M)
Cap (US$)
PE
2.281M
—
2.112M
—
Capital
TTM
5Y
10Y
Leveragex
1.443
(0.440)
(0.324)
EBIT/Intx
1.628
0.098
0.102
Own earn%
385.35
(25.18)
2.90
Sh yield%
25.77
2.48
6.36
Owners
Insiders/Inst%
9.90
35.90
Short interest%
3.17
SBC / revenue%
5.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
16–21
$1 testx
−0.1
Incr. ROIC%
4